Ticker

BCAX

Bicara Therapeutics Inc.

Get an email when a new filing names BCAX. A free account follows up to three names.Create a free account →

BCAX in the last 90 days

Bicara Therapeutics Inc. (BCAX) had no US House transactions and no insider purchases in filings from the last 90 days.

FINRA’s latest report (settlement 15 SEPT 2026) shows 11,191,724 shares held short, 22.6 days to cover, up 3.2% from the report before.

  • Delay: each filing below shows how many days passed between the trade and its publication. None of this is real-time.

Latest filing on file: — · FINRA settlement 15 SEPT 2026 · public filings, reported as filed

What the filings show

What the filings show · last 90 days · Quiet Money indicator

1 of 4 sources

-50Leaning out

Leaning outBalancedLeaning in

The disclosed money is leaning away from this name, on what has actually been filed. This reads on one source only, so treat it lightly.

Short interest
Short interest rose 20.1% — 9,315,906 to 11,191,724 shares between 15 JUL 2026 and 15 SEPT 2026. See the filings →
-50

This summarises filings that have already been published — it is not a forecast, a rating of the company, or advice. Every figure above is listed in full further down this page, with the document it came from.

FINRA short interest

Settlement 15 SEPT 2026 · shares held short

11,191,724shares held short

Days to cover

22.56

Avg daily volume

496,027

Since last report

+3.19%

As of 15 September 2026, 11,191,724 Bicara Therapeutics Inc. shares were held short — the total across every reporting firm, not one fund's position. That is 346,210 shares more than the previous report, a 3.19% increase. At the average daily volume of 496,027 shares, that position represents 22.56 days of trading — what the filing calls days to cover.

This is the most recent figure that exists, and it is 21 days old. FINRA collects short interest twice a month, on a settlement date, and publishes it seven business days later. So nobody has a live short-interest number for BCAX — not us, and not anyone quoting one. We print the settlement date on the figure so you always know which day you are looking at.

Across the 12 reports we hold, the position has risen from 9,639,901 shares on 31 March 2026 to 11,191,724 today, a change of 16.1%. The highest reading in that window was 11,191,724 shares on 15 September 2026.

SettlementShares shortDays to cover
15 SEPT 202611,191,72422.56
31 AUG 202610,845,51422.08
14 AUG 202610,463,18813.28
31 JUL 20269,597,40420.42
15 JUL 20269,315,90612.69
30 JUN 202610,121,6497.33
15 JUN 202610,160,39319.76
29 MAY 202610,083,30222.49
15 MAY 20269,849,29017.31
30 APR 20268,896,47221.35
15 APR 20269,325,84314.67
31 MAR 20269,639,90116.49
What is BCAX's short interest?
11,191,724 shares, as of the 15 September 2026 settlement date. That is the figure FINRA published, unadjusted.
What percentage of the float is short?
We do not publish that, because FINRA does not publish float. The regulator reports the number of shares held short; turning it into a percentage needs a share count from somewhere else, and different sources disagree about what counts as float. We would rather give you the number that was actually filed than a percentage built on an assumption.
How current is this?
It is 21 days old, and that is as fresh as short interest gets. FINRA measures it twice a month and publishes it seven business days after the settlement date. Any site showing you a "live" short interest figure is showing you something else.
What does days to cover mean?
It is the short position divided by average daily trading volume — here, 22.56. It describes how many days of ordinary trading the position is equivalent to. It is arithmetic from the filing, not a prediction about what will happen.
Where does this come from?
FINRA's consolidated short interest file, which is public. We read it directly and store it unchanged, except that we blank the days-to-cover placeholder FINRA writes when a stock has almost no volume.

Disclosed insider buying on file

—no purchase on file passed the price check

Open-market purchases only — the amount is a fact, not a verdict.

On file here

Short positions0

Insider purchases0

US House transactions0

Latest change—

SHORT POSITIONS · 0INSIDER BUYS · 0US HOUSE · 0
What this page will never showNo buy or sell ratingsNo price targetsNo forecastsIndicators are rules-based summaries of the filingsDocuments, dates, and how long they took to become public.